Nov 14 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2025 Sep 30, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 118 mln 255 mln 122 mln
(-53.9 pct) (+771.3 pct) (-52.5 pct)
Operating loss 742 mln loss 379 mln loss 1.34
Recurring loss 757 mln loss 343 mln loss 1.34
Net loss 769 mln loss 320 mln loss 1.35
EPS loss 14.84 yen loss 7.60 yen loss 22.75 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T